Regent Investment Management LLC Bausch Health Companies Inc. Transaction History

Regent Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$7.06 - $23.63 $7,060 - $23,630	-1,000 Reduced 5.85%	16,085 $134,000
Q1 2022 Apr 19, 2022	BUY	$21.6 - $27.79 $43,200 - $55,580	2,000 Added 13.26%	17,085 $390,000
Q4 2021 Jan 27, 2022	BUY	$23.0 - $29.01 $7,475 - $9,428	325 Added 2.2%	15,085 $416,000
Q3 2021 Oct 21, 2021	SELL	$25.04 - $30.06 $22,160 - $26,603	-885 Reduced 5.66%	14,760 $411,000
Q1 2021 Apr 20, 2021	SELL	$21.37 - $34.38 $184,850 - $297,387	-8,650 Reduced 35.6%	15,645 $497,000
Q4 2020 Jan 27, 2021	SELL	$15.31 - $21.12 $91,860 - $126,720	-6,000 Reduced 19.81%	24,295 $505,000
Q3 2020 Oct 19, 2020	SELL	$14.88 - $20.13 $26,784 - $36,234	-1,800 Reduced 5.61%	30,295 $471,000
Q2 2020 Jul 29, 2020	BUY	$13.31 - $20.51 $114,466 - $176,386	8,600 Added 36.6%	32,095 $587,000
Q1 2020 Apr 17, 2020	BUY	$12.98 - $30.25 $304,965 - $710,723	23,495 New	23,495 $364,000

264

250M

5.88M

9.78M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.23B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Investment Management LLC with notifications on news.